[Immunosuppression and blood transfusions in patients with a kidney transplant].
94 patients with renal allograft from a living related donor were studied in three different groups: 1 Patients with identical histocompatibility (n-32), treated with prednisone (PDN) and azathioprine (Aza); 2 Haploidentical patients (34) who received PDN, Aza and cyclosporine (CsA); 3 Haploidentical patients (28) who previous to the transplantation received specific donor blood transfusions and Aza/PDN after the transplantation. The survival for the patient and the graft after five years was 100% and 96% in group 1; 97% y 89% in group 2 and 82% and 72% in group 3. Five patients in group 1 received CsA also. There was no mortality in group 1, while there were one death in group 2 and two more in group 3. There was no significant difference between CsA and Blood transfusions in the patients and grafts survival.
Vázquez Salas
L
L
Unidad de Trasplante Renal, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS.
Arellano
J
J
MacGregor Gooch
J
J
Novelo
B
B
Lizola Margolis
I
I
Galván Plata
M E
ME
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D001803:Blood Transfusion / Q000706:statistics & numerical data; D016001:Confidence Intervals; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods* / Q000706:statistics & numerical data; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000706:statistics & numerical data; D008297:Male; D016017:Odds Ratio; D011241:Prednisone / Q000008:administration & dosage; D016019:Survival Analysis
D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone
Inmunosupresión y transfusiones sanguíneas en pacientes con trasplante renal.